Counseling for Harm Reduction and Retention in Medication-assisted Treatment - Cherokee Nation (CHaRRM-CN)
Opioid Use Disorder
About this trial
This is an interventional treatment trial for Opioid Use Disorder focused on measuring opioid use disorder, harm reduction, medication assisted treatment, American Indian
Eligibility Criteria
Inclusion Criteria: At least 18 years of age Must be newly registered (within 4 weeks) in the CNHS MAT Program. (Prior patients can participate as long as their most recent treatment course was at least 6 months prior). Must be willing to provide written informed consent to enroll in this study Exclusion Criteria: Refusal or inability to consent to participation in research. (The latter is assessed using the UCSD Brief Assessment of Capacity to Consent.) Refusal or inability to consent and constituting a risk to the safety and security of other patients or staff
Sites / Locations
- Cherokee Nation Health ServicesRecruiting
- University of Washington School of Medicine
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Treatment as Usual (TAU)
CHaRRM-CN
The TAU condition will entail the current CNHS MAT program for OUD.
The CHaRRM-CN condition comprises changes and additions to TAU codesigned with a community advisory board and taking into account suggestions from MAT patients and community members impacted by OUD with the goal of improving MAT retention in culturally aligned and community-driven ways.